top of page
Executive Spotlights

Japan's Takeda to buy Nimbus' Psoriasis Drug for as much as $6 bln

Tokyo, Japan, December 13, 2022 (Reuters) -- Takeda Pharmaceutical will buy U.S.-based Nimbus Therapeutics' experimental psoriasis drug for up to $6 billion, the Japanese drugmaker said on Tuesday, as it looks to cut reliance on treatments facing loss of patents.

Read full article here.

Recent Posts

See All
Life Science Headlines
bottom of page